/
/
/

Venus Remedies Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018
₹179 Cr₹259 Cr₹180 Cr₹193 Cr₹137 Cr₹198 Cr₹177 Cr₹170 Cr₹109 Cr₹195 Cr₹143 Cr₹168 Cr₹95 Cr₹156 Cr₹117 Cr₹140 Cr₹143 Cr₹142 Cr₹124 Cr₹203 Cr₹130 Cr₹111 Cr₹122 Cr₹126 Cr₹189 Cr₹83 Cr₹97 Cr₹88 Cr₹74 Cr₹90 Cr₹76 Cr₹88 Cr₹67 Cr
₹3 Cr₹5 Cr₹3 Cr₹2 Cr₹3 Cr₹4 Cr₹2 Cr₹8 Cr₹2 Cr₹4 Cr₹2 Cr₹3 Cr₹2 Cr₹3 Cr₹4 Cr₹2 Cr₹1 Cr₹2 Cr₹1 Cr₹3 Cr₹2 Cr₹3 Cr₹2 Cr₹12 Cr₹2 Cr₹1 Cr₹2 Cr₹1 Cr₹82 L₹4 Cr₹86 L₹3 Cr₹59 L
₹181 Cr₹264 Cr₹183 Cr₹194 Cr₹141 Cr₹202 Cr₹179 Cr₹178 Cr₹110 Cr₹199 Cr₹146 Cr₹171 Cr₹97 Cr₹159 Cr₹121 Cr₹142 Cr₹145 Cr₹144 Cr₹126 Cr₹205 Cr₹132 Cr₹115 Cr₹124 Cr₹138 Cr₹191 Cr₹84 Cr₹99 Cr₹89 Cr₹74 Cr₹95 Cr₹77 Cr₹92 Cr₹68 Cr
₹151 Cr₹203 Cr₹149 Cr₹168 Cr₹128 Cr₹171 Cr₹164 Cr₹169 Cr₹103 Cr₹182 Cr₹138 Cr₹156 Cr₹92 Cr₹139 Cr₹116 Cr₹136 Cr₹136 Cr₹144 Cr₹121 Cr₹184 Cr₹122 Cr₹116 Cr₹113 Cr₹124 Cr₹177 Cr₹82 Cr₹95 Cr₹84 Cr₹72 Cr₹97 Cr₹80 Cr₹81 Cr₹66 Cr
₹37 Cr₹68 Cr₹40 Cr₹33 Cr₹19 Cr₹36 Cr₹20 Cr₹15 Cr₹13 Cr₹23 Cr₹14 Cr₹21 Cr₹13 Cr₹28 Cr₹12 Cr₹15 Cr₹16 Cr₹8 Cr₹14 Cr₹30 Cr₹19 Cr₹8 Cr₹20 Cr₹23 Cr₹23 Cr₹9 Cr₹13 Cr₹14 Cr₹11 Cr₹6 Cr₹6 Cr₹19 Cr₹10 Cr
₹0₹1 L₹1 L₹1 L₹1 L₹1 L₹1 L₹2 L₹2 L₹2 L₹7 L₹2 L₹6 L₹0₹15 L₹0₹26 L₹0₹31 L₹3 L₹14 L₹96 L₹2 Cr₹7 Cr₹3 Cr-₹2 Cr₹4 Cr₹5 Cr₹6 Cr₹0₹10 Cr₹11 Cr₹8 Cr
₹30 Cr₹62 Cr₹33 Cr₹26 Cr₹13 Cr₹31 Cr₹25 Cr₹9 Cr₹7 Cr₹17 Cr₹8 Cr₹14 Cr₹5 Cr₹20 Cr₹5 Cr₹6 Cr₹8 Cr₹23 L₹5 Cr₹21 Cr₹10 Cr₹18 Cr₹14 Cr₹15 Cr₹2 Cr-₹5 Cr₹2 L₹58 L-₹4 Cr-₹12 Cr-₹12 Cr-₹8 L-₹6 Cr
₹23 Cr₹47 Cr₹26 Cr₹20 Cr₹10 Cr₹21 Cr₹20 Cr₹4 Cr₹1 Cr₹11 Cr₹7 Cr₹10 Cr₹1 Cr₹11 Cr₹3 Cr₹5 Cr₹7 Cr₹23 L₹6 Cr₹23 Cr₹12 Cr₹35 Cr₹12 Cr₹13 Cr₹2 Cr-₹5 Cr-₹96 L₹42 L-₹4 Cr-₹11 Cr-₹12 Cr₹41 L-₹6 Cr

Share Price Live Stats

Open (₹)1,705.00
Volume (₹)12,349.00
High (₹)1,778.80
Upper Circuit1,786.90
Low (₹)1,701.90
Lower Circuit1,616.90
Prev Close1,701.90
52W High (₹)2,044.30
Price1,705.30
52W Low (₹)424.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)2285.62 Cr
Div. Yield (%)0.58
PE Ratio19.67
Debt to Equity0.00
Price to Book1.66
Book Value496.56
EPS (TTM)86.91
Face Value10.00
ROE (%)16.79

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
VENUSREM-BENSE
LTP
1W Low
1W High
Market cap (₹)
1905.6-14.4 (-0.75%)
1902
1984.80
4,56,833Cr
9216-23 (-0.25%)
9087
9467
2,45,426Cr
4892-158 (-3.13%)
4885
5066
1,87,320Cr
1133.7-57.3 (-4.81%)
1125.10
1187
1,13,217Cr
1391.2-32.3 (-2.27%)
1376.70
1426.10
1,12,212Cr
1853.9-84.6 (-4.36%)
1811.70
1949
1,01,155Cr
2127-44.5 (-2.05%)
2118.10
2192
97,626Cr
2350.6-32.3 (-1.36%)
2341.20
2419.20
96,859Cr
1164.1-13.9 (-1.18%)
1154.40
1179.90
96,406Cr
1656.5+11.2 (0.68%)
1622.60
1717
93,614Cr
1705.3+78.6 (4.83%)
1571.10
1778.80
2,286Cr

Key Highlights of Venus Remedies Ltd’s P&L

In 2026-03-31, Venus Remedies Ltd reported total revenue of ₹782.18Cr, compared with ₹668.84Cr in 2025-03-31, reflecting Venus Remedies Ltd turnover.

Depreciation was ₹25.67Cr and finance costs were ₹3.67Lakh in 2026-03-31

Profit Before Tax (PBT) has been ₹134.15Cr in 2026-03-31 as compared to ₹71.83Cr in 2025-03-31.

Net Profit (PAT) was ₹102.79Cr in 2026-03-31 compared with ₹45.31Cr in 2025-03-31.

Earnings per share (EPS) were ₹76.90 in 2026-03-31, compared with ₹33.90 in 2025-03-31.